Finally, a global approach to precision GI care.
We’re on a mission to bring world-class care and treatment to patients around the world. Advances in machine learning and artificial intelligence are helping us create a complete GI ecosystem with the power to turn this vision into reality.
AI and ML: driving the future of therapeutic GI care.
The level of precision we’re now introducing to GI care would have been unimaginable just a generation ago. As our name implies, success in this endeavor requires consistently building on a series of incremental advances. In this, our mission is clear.
Thought leadership in action.
It’s enormously gratifying to see our pioneering work highlighted as the cover feature of the September 2022 issue of Gastroenterology, the official journal of the AGA Institute. The Iterative Health team continues to grow by attracting many of the preeminent minds in our field.
CLINICAL TRIAL OPTIMIZATION
Iterative Health offers a combination of services and technology that maximizes the value of a clinical research practice.
Greater accuracy is good for everyone.
Advances in precision medicine continue to raise the bar for both accuracy and consistency in diagnostics. SKOUT™ focuses on applying these breakthrough benefits specifically within the field of gastroenterology.1
SKOUT augments but does not replace physician judgement.
Our AI-enhanced approach will significantly improve adenoma detection.3 This will translate to better care for millions of patients around the world.
A scalable, more equitable approach to GI care.
AI-enabled documentation technology has the potential to improve both quality and continuity of patient care. With standardized, high-quality reporting across institutions, this same high standard of care can finally become a reality for previously underserved populations.